Subtopic Deep Dive
Anti-inflammatory Pharmacology of Phyllanthus
Research Guide
What is Anti-inflammatory Pharmacology of Phyllanthus?
Anti-inflammatory Pharmacology of Phyllanthus examines the mechanisms by which phytochemicals from Phyllanthus species inhibit COX-2, NF-κB pathways, and cytokine production in validated inflammation models.
Phyllanthus extracts demonstrate anti-inflammatory effects through NF-κB, MAPK, and PI3K-Akt pathway inhibition in LPS-induced macrophages (Harikrishnan et al., 2018). Key compounds like corilagin and bergenin reduce phagocytic activity and cytokine levels in neutrophils (Jantan et al., 2014). Over 10 major reviews and studies since 2006 document these properties across P. niruri, P. amarus, and P. urinaria, with 255 citations for the foundational review by Bagalkotkar et al. (2006).
Why It Matters
Phyllanthus compounds inhibit NF-κB and MAPK pathways, reducing pro-inflammatory cytokines in LPS-stimulated human macrophages, positioning them as leads for arthritis therapies (Harikrishnan et al., 2018; 100 citations). Extracts from P. amarus and P. urinaria suppress neutrophil phagocytosis, offering potential for chronic inflammatory diseases like rheumatoid arthritis (Jantan et al., 2014; 213 citations). Nanoemulsion formulations of P. urinaria extracts neutralize reactive oxygen species for skin inflammation applications (Mahdi et al., 2011; 85 citations). These validated models support drug development from traditional remedies.
Key Research Challenges
Standardizing Active Compounds
Variability in lignans, flavonoids, and polyphenols across Phyllanthus species complicates reproducible anti-inflammatory effects (Bagalkotkar et al., 2006). Correlation studies link specific components like geraniin to neutrophil inhibition, but extraction methods differ (Jantan et al., 2014). Standardization protocols remain inconsistent.
Elucidating Pathway Mechanisms
Inhibition of NF-κB, MAPK, and PI3K-Akt pathways requires detailed signaling studies in human models (Harikrishnan et al., 2018). Few papers dissect compound-specific targets beyond COX-2 and cytokine reduction. In vivo translation from edema assays lags.
Clinical Translation Barriers
Preclinical efficacy in carrageenan paw edema lacks phase I trials for Phyllanthus leads (Mao et al., 2016). Nanoformulations show promise but face bioavailability hurdles (Mahdi et al., 2011). Regulatory validation of ethnomedicinal claims is limited.
Essential Papers
Phytochemicals from <i>Phyllanthus niruri</i> Linn. and their pharmacological properties: a review
Gururaj Bagalkotkar, Sreenivasa Rao Sagineedu, Mohammad Said Saad et al. · 2006 · Journal of Pharmacy and Pharmacology · 255 citations
Abstract This review discusses the medicinal plant Phyllanthus niruri Linn. (Euphorbiaceae), its wide variety of phytochemicals and their pharmacological properties. The active phytochemicals, flav...
Correlation between the major components of Phyllanthus amarus and Phyllanthus urinaria and their inhibitory effects on phagocytic activity of human neutrophils
Ibrahim Jantan, Menaga Ilangkovan, Yuandani Yuandani et al. · 2014 · BMC Complementary and Alternative Medicine · 213 citations
Recently, we have highlighted the immunomodulatory activity of the standardized extracts of Phyllanthus amarus and P. urinaria. The present study was carried out to correlate between the prevalent ...
The Genus <i>Phyllanthus</i>: An Ethnopharmacological, Phytochemical, and Pharmacological Review
Xin Mao, Ling-Fang Wu, Hong-Ling Guo et al. · 2016 · Evidence-based Complementary and Alternative Medicine · 131 citations
The plants of the genus Phyllanthus (Euphorbiaceae) have been used as traditional medicinal materials for a long time in China, India, Brazil, and the Southeast Asian countries. They can be used fo...
An Insight Into the Modulatory Effects and Mechanisms of Action of Phyllanthus Species and Their Bioactive Metabolites on the Immune System
Ibrahim Jantan, Md. Areeful Haque, Menaga Ilangkovan et al. · 2019 · Frontiers in Pharmacology · 122 citations
<i>Phyllanthus</i> species (family; <i>Euphorbiaceae</i>) have been intensively studied for their immunomodulating effects due to their wide-ranging uses to treat immune-related diseases in indigen...
A Review of the Phytochemistry and Pharmacology of Phyllanthus urinaria L.
Madamanchi Geethangili, Shih‐Torng Ding · 2018 · Frontiers in Pharmacology · 120 citations
The genus <i>Phyllanthus</i> (L.) is one of the most important groups of plants belonging to the Phyllantaceae family. <i>Phyllanthus urinaria</i> (L.) is an annual perennial herbal species found i...
Advances in biotechnology of Emblica officinalis Gaertn. syn. Phyllanthus emblica L.: a nutraceuticals-rich fruit tree with multifaceted ethnomedicinal uses
Saikat Gantait, Manisha Mahanta, Soumen Bera et al. · 2021 · 3 Biotech · 108 citations
Anti-inflammatory effects of Phyllanthus amarus Schum. & Thonn. through inhibition of NF-κB, MAPK, and PI3K-Akt signaling pathways in LPS-induced human macrophages
Hemavathy Harikrishnan, Ibrahim Jantan, Md. Areeful Haque et al. · 2018 · BMC Complementary and Alternative Medicine · 100 citations
Reading Guide
Foundational Papers
Start with Bagalkotkar et al. (2006; 255 citations) for P. niruri phytochemical overview, then Jantan et al. (2014; 213 citations) for phagocytosis correlations establishing immunomodulatory baselines.
Recent Advances
Study Harikrishnan et al. (2018; 100 citations) for NF-κB pathway details and Jantan et al. (2019; 122 citations) for immune modulatory mechanisms in human models.
Core Methods
Core techniques include LPS-stimulated macrophage assays for signaling pathways, carrageenan-induced paw edema for in vivo efficacy, HPLC for compound quantification, and Western blots for NF-κB/p65 expression (Harikrishnan et al., 2018; Jantan et al., 2014).
How PapersFlow Helps You Research Anti-inflammatory Pharmacology of Phyllanthus
Discover & Search
Research Agent uses searchPapers with query 'Phyllanthus anti-inflammatory NF-κB' to retrieve 50+ papers including Harikrishnan et al. (2018), then citationGraph reveals Jantan et al. (2014) as a hub with 213 citations, and findSimilarPapers expands to immunomodulatory mechanisms.
Analyze & Verify
Analysis Agent applies readPaperContent to extract NF-κB inhibition data from Harikrishnan et al. (2018), verifies cytokine reduction claims via verifyResponse (CoVe) against Bagalkotkar et al. (2006), and runs PythonAnalysis to meta-analyze IC50 values across 10 papers using pandas for GRADE evidence grading.
Synthesize & Write
Synthesis Agent detects gaps in clinical translation from pathway studies, flags contradictions between in vitro neutrophil data and edema models, then Writing Agent uses latexEditText for methods sections, latexSyncCitations for 20+ references, and latexCompile to generate a review manuscript with exportMermaid diagrams of NF-κB cascades.
Use Cases
"Extract and plot IC50 values for Phyllanthus extracts on NF-κB inhibition from top 5 papers"
Research Agent → searchPapers → Analysis Agent → readPaperContent on Harikrishnan et al. (2018) → runPythonAnalysis (pandas plot of IC50s with matplotlib) → researcher gets CSV export and GRADE-scored meta-analysis plot.
"Draft LaTeX review on corilagin mechanisms in Phyllanthus anti-inflammation"
Synthesis Agent → gap detection → Writing Agent → latexEditText for intro → latexSyncCitations with Jantan et al. (2014) → latexCompile → researcher gets compiled PDF with figure legends and bibliography.
"Find code for analyzing Phyllanthus phytochemical HPLC data"
Research Agent → searchPapers('Phyllanthus HPLC analysis') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets Python scripts for peak identification linked to Jantan et al. (2014) methods.
Automated Workflows
Deep Research workflow scans 50+ Phyllanthus papers via searchPapers → citationGraph → DeepScan's 7-step verification with CoVe checkpoints on NF-κB claims from Harikrishnan et al. (2018). Theorizer generates hypotheses on corilagin's COX-2 binding from Jantan et al. (2014) and Bagalkotkar et al. (2006), outputting mermaid pathway diagrams.
Frequently Asked Questions
What defines Anti-inflammatory Pharmacology of Phyllanthus?
It studies phytochemicals from Phyllanthus species inhibiting COX-2, NF-κB pathways, and cytokines in models like paw edema (Harikrishnan et al., 2018).
What are key methods used?
Researchers use LPS-induced macrophage assays for NF-κB/MAPK inhibition, carrageenan paw edema for efficacy, and neutrophil phagocytosis tests (Jantan et al., 2014; Harikrishnan et al., 2018).
What are the most cited papers?
Bagalkotkar et al. (2006; 255 citations) reviews P. niruri phytochemicals; Jantan et al. (2014; 213 citations) correlates components to phagocytosis inhibition.
What open problems exist?
Challenges include standardizing extracts for clinical trials and dissecting compound-specific pathway targets beyond in vitro models (Mao et al., 2016).
Research Phytochemistry and Bioactivity Studies with AI
PapersFlow provides specialized AI tools for Pharmacology, Toxicology and Pharmaceutics researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Anti-inflammatory Pharmacology of Phyllanthus with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Pharmacology, Toxicology and Pharmaceutics researchers